Schedule 13G ownership disclosure

ESPERION THERAPEUTICS, INC.

Security class unavailable · CUSIP: 29664W105

Event date: 2024-01-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-24-014199
Form type
SC 13G/A
Filer
BB BIOTECH AG
CIK
CIK 924223
Filed
Jan 24, 2024
Reporting period
Jan 19, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub